Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
With a market cap of 1.09B, Replimune(REPL) trades at $12.00. The stock has a price-to-earnings ratio of -3.44.
During the trading session on 2026-08-09, Replimune(REPL) shares reached a daily high of $13.40 and a low of $11.42. At a current price of $12.00, the stock is +5.1% higher than the low and still -10.4% under the high.
Trading volume for Replimune(REPL) stock has reached 8.91M, versus its average volume of 11.86M.
Over the past 52 weeks, Replimune(REPL) stock has traded between a high of $13.90 and a low of $1.50.
Over the past 52 weeks, Replimune(REPL) stock has traded between a high of $13.90 and a low of $1.50.
REPL News
...
Replimune Group (REPL) stock is back in focus after Robbins LLP announced a securities class action tied to the company’s RP1 melanoma program and the U.S. Food...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Analyst ratings
100%
of 7 ratingsMore REPL News
As previously reported, Wedbush upgraded Replimune (REPL) to Outperform from Neutral with a price target of $19, up from $12. The firm notes the Food and Drug A...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.